Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-031384

CBO & EVP sold 363 shares at $113.69 ($41,269)

From the SEC's structured data for this filing

Trades in this filing

Kassberg Thomas Richard · CBO & EVP

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-06 Sale : show line 1 in the form −363 $113.69 $41,269 106,818 D
Open-market sales · 363 sh · avg $113.69 · $41,269
Loading xslF345X03/doc4.xml…